Korean Drug Co. Ltd (014570) — Cash Flow Quality Index
Korean Drug Co. Ltd (014570) has a Cash Flow Quality Index of 5.49x as of March 2026. Operating cash flow of ₩6.60 Billion exceeds net income of ₩1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore 014570 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Korean Drug Co. Ltd Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Korean Drug Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Korean Drug Co. Ltd (014570) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Korean Drug Co. Ltd (2014–2025)
Year-by-year earnings quality comparison for Korean Drug Co. Ltd. For live market cap and the full company financial profile, see Korean Drug Co. Ltd market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | ₩13.11 Billion | ₩6.51 Billion | ▲ +23.8% |
| 2024 | 1.63x | ₩4.87 Billion | ₩3.00 Billion | ▲ +224.7% |
| 2022 | 0.50x | ₩5.91 Billion | ₩11.81 Billion | ▼ -48.6% |
| 2021 | 0.97x | ₩8.81 Billion | ₩9.04 Billion | ▼ -41.9% |
| 2020 | 1.68x | ₩12.33 Billion | ₩7.36 Billion | ▲ +5.1% |
| 2019 | 1.59x | ₩6.21 Billion | ₩3.90 Billion | ▲ +80.7% |
| 2018 | 0.88x | ₩5.79 Billion | ₩6.56 Billion | ▲ +823.6% |
| 2017 | 0.10x | ₩447.20 Million | ₩4.68 Billion | ▼ -87.8% |
| 2016 | 0.78x | ₩3.96 Billion | ₩5.05 Billion | ▼ -77.3% |
| 2015 | 3.46x | ₩6.13 Billion | ₩1.77 Billion | ▲ +66.7% |
| 2014 | 2.07x | ₩4.46 Billion | ₩2.15 Billion | — |